Penetration of new antidiabetic medications in East Asian countries and the United States: A cross-national comparative study.

ABSTRACT:

Background

The number of patients with diabetes is increasing particularly in Asia-Pacific region. Many of them are treated with antidiabetics. As the basis of the studies on the benefit and harm of antidiabetic drugs in the region, the information on patterns of market penetration of new classes of antidiabetic medications is important in providing context for subsequent research and analyzing and interpreting results.

Methods

We compared penetration patterns of dipeptidyl peptidase-4 (DPP-4) inhibitors in Taiwan, Hong Kong, Japan, and the United States. We used the Taiwan National Health Insurance Research Database, a random sample of the Hong Kong Clinical Data Analysis and Reporting System, the Japan Medical Data Center database, and a 5% random sample of the US Medicare

SUBMITTER: Kubota K 

PROVIDER: S-EPMC6291148 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature